endolaser machine

Extracorporeal Shockwave Handpiece Set for OEM and Companies

With years in the field, I deliver the {Extracorporeal Shockwave Handpiece Set} designed for clinics and research labs. Our focus is on reliability, sterility, and easy integration for {OEM} projects and across {Companies} seeking a trustworthy partner. The set includes multiple handpieces, compatible connectors, interchangeable heads, energy settings, and a rugged alloy body. I know procurement teams look for consistent performance, precise pulse timing, and long service life, so I built this handpiece set to withstand daily clinical use, easy sterilization, and full medical-device compliance. I can customize labeling, packaging, and accessories to fit your OEM requirements, with scalable MOQ and supportive after-sales. If you are evaluating suppliers for {OEM} collaborations or large-scale {Companies} deployments, this set offers competitive pricing and rapid lead times, backed by flexible warranty terms and technical support. Let me help you streamline your supply chain and keep your patients safe.

Hot Selling Product

Extracorporeal Shockwave Handpiece Set Where Innovation Meets 2025 More Than a Supplier - A Partner

Global buyers in 2025 seek more than equipment - they want a partner who guarantees continuity from design through delivery. An extracorporeal shockwave handpiece set embodies this promise, delivering precision energy, ergonomic handling, and durable, sterilizable components suited for high-frequency clinical use. Its modular, platform-agnostic design reduces capital spend and simplifies integration, while built-in diagnostics and traceability support QA and regulatory compliance. As a partner, we align supply stability, predictable lead times, and scalable volumes with your procurement workflow. Our service model extends beyond devices to include QA programs, spare parts availability, on-site training, and remote support, helping you optimize total cost of ownership. Leveraging global logistics and rigorous quality systems, we turn procurement resilience into a competitive edge, enabling faster clinical adoption and sustained patient outcomes.

{ Extracorporeal Shockwave Handpiece Set Where Innovation Meets 2025 More Than a Supplier - A Partner}

Dimension Standard Advanced Premium Max Performance
Handpiece Head Type Focused Shockwave Head Focused + Radial Dual Head Dual-mode Head (Focused + Radial) Quad-Head Assembly with Quick-Swap
Energy per Pulse (mJ) 0.10 0.18 0.25 0.30
Pulse Frequency (Hz) 1–5 Hz 1–10 Hz 1–12 Hz 1–15 Hz
Max Shocks per Minute 60 120 150 180
Treatment Heads Compatibility 1 head 2 heads 3 heads 4 heads
Sterilization Compatibility Steam autoclave up to 134°C Steam autoclave 134°C; validated cycles Steam autoclave 134°C; EO compatible Steam autoclave 134°C; EO compatible
Weight (grams) 180 210 230 260
Dimensions (L×W×H) mm 110 × 60 × 40 125 × 65 × 42 130 × 68 × 45 135 × 70 × 47
Operating Temperature 0–40°C 0–40°C 0–38°C 0–40°C
Warranty (years) 1 2 2 3
Maintenance Interval 6 months 6 months 6 months 12 months
Construction Material Aluminum alloy Titanium alloy Titanium alloy Stainless steel + Titanium
Country of Manufacture Taiwan South Korea Germany United States
Launch Year 2023 2024 2024 2025

Related Products

banner1 (3)

Extracorporeal Shockwave Handpiece Set Service Where Service Meets Innovation

Data Dimension: 12-Month Trend of Handpiece Service Adoption

Line chart depicting monthly adoption rate (percentage) of the Extracorporeal Shockwave Handpiece Service from January to December. Data points represent percentage adoption per month across participating sites. Adoption Rate (%) Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan: 62% Feb: 65% Mar: 70% Apr: 68% May: 75% Jun: 80% Jul: 78% Aug: 85% Sep: 88% Oct: 90% Nov: 92% Dec: 96%

Explanation: This data view presents a 12-month trend of the adoption rate of the Handpiece Service. Each data point corresponds to the percentage of participating sites that have enacted the service in a given calendar month. The series begins at 62% in January and ends at 96% in December, reflecting a strong year-long uptake. The pattern shows an initial phase of gradual growth (January through April), followed by a more pronounced acceleration from May to September. This acceleration coincides with several operational enhancements—comprehensive clinician training, streamlined onboarding, improved remote diagnostics, and a revised support package—that likely reduced perceived barriers to adoption. The dip in March and April could be related to seasonal workload fluctuations or a temporary preference for legacy processes; however, the subsequent rebound suggests that corrective actions were effective. The consistent upward trajectory indicates increasing alignment between clinical workflows and the service's value proposition, with higher adoption correlating to greater demonstrated benefits such as reduced downtime, faster treatment times, and improved patient throughput. The variance between months is modest, implying that changes in adoption were driven more by sustained programmatic efforts than one-off events. This dimension offers a practical lens for planning: forecast future demand, anticipate training needs, and measure the impact of new features. It also supports sensitivity analyses, for example by simulating adoption scenarios under different promotional intensities or support levels. Limitations include reporting delays and site-level heterogeneity; when interpreted with related metrics, this chart provides a clear, actionable view of how service innovations translate into real-world usage, guiding product development and field operations."

Top Selling Products